Literature DB >> 1734297

'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus.

K Minematsu1, T Yamaguchi, T Omae.   

Abstract

We studied the clinical features of a major hemispheric stroke syndrome with rapid recovery ("spectacular shrinking deficit" [SSD]) compared with stroke patients with the same major initial manifestations but without rapid recovery (non-SSD). There were 118 patients with an initial major hemispheric syndrome; 14 patients (12%) had SSD. All but one SSD patient met criteria for cardiogenic brain embolism. Angiographic examination within 24 hours after stroke onset demonstrated that the occlusion sites in SSD differed from those in non-SSD and suggested that rapid embolus migration had occurred in all SSD patients but in only five of 39 non-SSD. Infarcts in SSD were smaller and often scattered over the cortices and deeper structures. Hemorrhagic transformation was less frequent in SSD. In patients with a potential cardiac source of emboli, SSD was more likely to occur in nondiabetic men less than 60 years of age.

Entities:  

Mesh:

Year:  1992        PMID: 1734297     DOI: 10.1212/wnl.42.1.157

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 2.  Cerebral vascular dysregulation in the ischemic brain.

Authors:  Alexander Kunz; Costantino Iadecola
Journal:  Handb Clin Neurol       Date:  2009

Review 3.  Thrombolytic therapy. From myocardial to cerebral infarction. The MAST-I Group. Multicentre Acute Stroke Trial.

Authors:  L Candelise; C Roncaglioni; E Aritzu; A Ciccone; A P Maggioni
Journal:  Ital J Neurol Sci       Date:  1996-02

4.  Ventriculo-lumbar perfusion in acute ischemic stroke.

Authors:  Rodney D Bell; Barbara L Powers; David Brock; J Javier Provencio; Adam Flanders; Ronald Benetiz; Robert Rosenwasser; Jamie Strause; Glenn Frazer; Michael S Kramer; David Hesson; James Barnitz; J L Osterholm
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

5.  Effect of clot aging and cholesterol content on ultrasound-assisted thrombolysis.

Authors:  Yufeng Zhou; Suresh Kanna Murugappan; Vijay Kumar Sharma
Journal:  Transl Stroke Res       Date:  2014-02-03       Impact factor: 6.829

6.  Emergency Department Length of Stay and Outcome after Ischemic Stroke.

Authors:  Artin Minaeian; Anand Patel; Basad Essa; Richard P Goddeau; Majaz Moonis; Nils Henninger
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-05-24       Impact factor: 2.136

7.  Transient basilar artery occlusion monitored by transcranial color Doppler presenting with a spectacular shrinking deficit: a case report.

Authors:  Giuseppe Nicoletti; Gerardina Albano; Sandro Sanguigni; Salvatore Tardi; Giovanni Malferrari; Massimo Del Sette; Filomena Bruno; Aldo Nicolai
Journal:  J Med Case Rep       Date:  2010-01-19

8.  Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study.

Authors:  Sonu Bhaskar; Andrew Bivard; Peter Stanwell; Mark Parsons; John R Attia; Michael Nilsson; Christopher Levi
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

9.  Impact of reperfusion after 3 hours of symptom onset on tissue fate in acute cerebral ischemia.

Authors:  Oh Young Bang; David S Liebeskind; Brian H Buck; Sa Rah Yoon; Jeffry R Alger; Bruce Ovbiagele; Jeffrey L Saver
Journal:  J Neuroimaging       Date:  2008-10-21       Impact factor: 2.486

Review 10.  Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke.

Authors:  Paulina E Gąsiorek; Maciej Banach; Marek Maciejewski; Andrzej Głąbiński; Aleksandra Paduszyńska; Jacek Rysz; Agata Bielecka-Dąbrowa
Journal:  Cardiol J       Date:  2018-05-02       Impact factor: 2.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.